Crizanlizumab in Sickle Cell Disease
N Engl J Med
.
2017 May 4;376(18):1796.
doi: 10.1056/NEJMc1703162.
Authors
Kenneth I Ataga
1
,
Abdullah Kutlar
2
,
Julie Kanter
3
Affiliations
1
University of North Carolina, Chapel Hill, NC kataga@med.unc.edu.
2
Medical College of Georgia, Augusta, GA.
3
Medical University of South Carolina, Charleston, SC.
PMID:
28467874
DOI:
10.1056/NEJMc1703162
No abstract available
Publication types
Letter
Comment
MeSH terms
Anemia, Sickle Cell*
Humans